Related Experiment Video
Updated: Jul 17, 2026

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
Published on: June 19, 2014
HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features
Fusheng Li1, Helen Horton, Peter B Gilbert
1Statistical Center for HIV/AIDS Research and Prevention, 1100 Fairview Avenue N, Seattle, WA 98109, USA. Fusheng@scharp.org.
Developing effective HIV-1 vaccines is challenging due to viral diversity and limited understanding of vaccine immunology. This study proposes strategies to broaden immune responses for better vaccine efficacy against HIV-1.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Current Human Immunodeficiency Virus type 1 (HIV-1) vaccine research prioritizes T-cell immunity for infection containment.
- Development of effective cytotoxic T-lymphocyte (CTL)-based HIV-1 vaccines is hampered by viral antigenic diversity and incomplete knowledge of vaccine immunology.
Purpose of the Study:
- To analyze the epitope coverage of circulating HIV-1 strains by existing vaccine strategies.
- To propose novel approaches for enhancing vaccine-induced immune responses and improving potential protective efficacy.
Main Methods:
- Analysis of potential epitope coverage (E(c)) against circulating HIV-1 strains using current vaccine strategies.
- Consideration of parsimonious features of cellular immune responses in modulating vaccine specificities.
Main Results:
- Identified limitations in epitope coverage of current HIV-1 vaccine strategies against diverse viral strains.
- Highlighted the importance of cellular response features in optimizing vaccine design.
Conclusions:
- Proposed approaches to enhance the breadth of vaccine responses against HIV-1.
- Emphasized the need to incorporate cellular immune response characteristics for improved HIV-1 vaccine development and potential protective efficacy.
More Related Videos
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Vaccinations
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...